Showing results (31-40 of 36) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Expert Opinion on Drug Safety|October 27, 2004
Disturbance of vision by COX-2 inhibitorsDavid M Coulter, David W J ClarkDrug Safety|May 15, 2004
Do some inhibitors of COX-2 increase the risk of thromboembolic events?: Linking pharmacology with pharmacoepidemiologyDavid W J Clark, Deborah Layton, Saad A W ShakirDrug Safety|December 15, 2010
Clinical implications of pharmacogenetic variation on the effects of statinsSimran D S Maggo, Martin A Kennedy, David W J ClarkDrug Safety|December 14, 2004
Linking pharmacovigilance with pharmacogeneticsDavid W J Clark, Emma Donnelly, David M Coulter, et al.Headache|September 27, 2003
Activation of pain by sumatriptanDavid M Coulter, J L M Passier, David W J Clark, et al.Pharmacoeconomics|August 11, 2006
Pharmacoeconomic analyses of azathioprine, methotrexate and prospective pharmacogenetic testing for the management of inflammatory bowel diseaseVirginia L Priest, Evan J Begg, Sharon J Gardiner, et al.Pageof 4